The Board of Directors of Morepen Laboratories have approved the appointment of Amrit Ravi as ‘Lead - Emerging Opportunities’, in the rank of Vice President of the company with effect from 1st October, 2024.

Ravi is a seasoned, healthcare business leader with nearly 15 years of experience in building impactful, technology-driven healthcare enterprises. He possesses a unique blend of innovation, strategic execution, and a pragmatic approach that has consistently led to successful outcomes in complex environments. His expertise encompasses P&L management, driving revenue growth, and developing health tech, medical devices, and FMCG categories, making him well-equipped to navigate the rapidly evolving landscape of healthcare.

He holds a Master’s in Management from the National University of Singapore and a B Tech in Information Science with a focus on Bioinformatics from Vellore Institute of Technology. His academic background complements his practical experience, providing him with a unique blend of analytical and strategic skills. 

With expertise in corporate strategy, product innovation, and building high-performance teams, Ravi is poised to bring significant value to organizations seeking to identify new opportunities in the healthcare segment globally, while enhancing operational efficiency and driving revenue growth in the evolving health tech landscape. His vision for next-generation digital health solutions positions him as an exceptional candidate for future opportunities.